FDA Inspection 748400 — Daito Pharmaceutical Co., Ltd.

Daito Pharmaceutical Co., Ltd. — FEI 3002806779

The FDA completed an inspection of Daito Pharmaceutical Co., Ltd. on Sep 29, 2011 in Toyama. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 29, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Toyama (Japan)